Promino Nutritional Sciences Inc

As of June 30, 2026, Promino Nutritional Sciences Inc carries a market capitalization of 6.44M, placing it among publicly traded companies globally. Its enterprise value stands at 8.18M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, Promino Nutritional Sciences Inc has 214.50M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 2.79, and the price-to-book ratio stands at -0.97.

These figures are as of June 30, 2026. The EV/Sales ratio of 4.81 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 8.18M versus a market cap of 6.44M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Promino Nutritional Sciences Inc maintains a current ratio of 0.15, meaning it holds 0.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -26.61, indicating conservative leverage, while an interest coverage ratio of -9.84 demonstrates limited ability to service its debt obligations.

These figures cover the twelve months ended June 30, 2026. Return on assets (ROA) is negative at -245.56, reflecting losses generated across the asset base. The company generates approximately 121,430.86 in revenue per employee across its workforce of 14.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 2.15 indicates how many times Promino Nutritional Sciences Inc sells and replaces its inventory over a year, a key working capital efficiency ratio.

As of the close on October 22, 2026, Promino Nutritional Sciences Inc's stock has declined approximately 60.00% over the past 52 weeks. The 50-day moving average sits at 0.03, while the 200-day moving average is 0.03.

Over the twelve months ended June 30, 2026, Promino Nutritional Sciences Inc generated 1.70M in revenue and converted that into -2.44M in net income, yielding earnings per share of -0.02. EBITDA reached -2.93M, while operating income came in at -2.93M.

As of June 30, 2026, Promino Nutritional Sciences Inc holds 11,508.00 in cash and equivalents against 1.76M in total debt, resulting in a net debt position of 1.75M. Total book value stands at -6.60M, with working capital of -6.60M providing operational flexibility.

Promino Nutritional Sciences Inc produced -2.13M in operating cash flow over the twelve months ended June 30, 2026.

Over the twelve months ended June 30, 2026, Promino Nutritional Sciences Inc posted a gross margin of 6.64, reflecting its pricing power and cost economics. The operating margin of -172.58 and net profit margin of -143.69 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -44.58: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -31.75, meaning Promino Nutritional Sciences Inc raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Promino Nutritional Sciences Inc's most recent stock split took place on April 1, 2024 with a 3:1 split ratio.

As of June 30, 2026, Promino Nutritional Sciences Inc has an Altman Z-Score of -73.32, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.